GlaxoSmithKline obtains injunction against extremists

GlaxoSmithKline has revealed that it has obtained a High Court injunction against the animal extremists who wrote a threatening letter to shareholders and investors.

The letter’s authors said they would publish the details of any Glaxo shareholders who did not sell off their stocks on a website. They also promised that Glaxo shares would crash. They are currently trading down by 11 pence, a 0.94 per cent reduction, although they did rise by 15 pence on the day the letters were revealed.

On Monday Glaxo condemned the letters, telling their shareholders to report them to the police. The company also said worried shareholders could transfer their stock to a private nominee fund.

The injunction obtained today prohibits anyone related to the production of the letter from harassing Glaxo shareholders, including the publishing of their details on a website.

The UK-based firm stated: “The Company is determined to make every effort to protect its shareholders and this injunction supports those efforts being made by the Police, who are taking this matter very seriously, and are conducting a criminal investigation into these matters.”

Yesterday, the European director for People for the Ethical Treatment of Animals refused to condemn the letters. Poorva Johipurva told Channel 4 News: “The letter which has been sent to these shareholders is, as far as I can see, an informative letter which informs them that they are fuelling cruelty to animals by supporting GlaxoSmithKline.”

© Adfero Ltd